Research in Real-Life Ltd

Quick facts

Marketed products

• Fluticasone 125/formoterol 5 · Respiratory
  Fluticasone/formoterol is a combination inhaled corticosteroid and long-acting beta-2 agonist that reduces airway inflammation and dilates airways to improve breathing.
• Fluticasone 250/formoterol 10 · Respiratory
  Fluticasone/formoterol is an inhaled combination of a corticosteroid and a long-acting beta-2 agonist that reduces airway inflammation and dilates airways to improve breathing.
• Fluticasone 250/salmeterol 25 · Respiratory
  Fluticasone/salmeterol is a combination inhaled corticosteroid and long-acting beta-2 agonist that reduces airway inflammation and dilates airways to improve breathing.
• Qvar (100 mcg) · Respiratory / Pulmonology
  Qvar is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in lung tissue.

Phase 2 pipeline

• Chlorofluorocarbon beclomethasone dipropionate · Respiratory / Pulmonology
  Beclomethasone dipropionate is a corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors in the lungs.
• Chlorofluorocarbon beclomethasone metered dose inhaler · Respiratory
  Beclomethasone dipropionate is a corticosteroid that binds to glucocorticoid receptors, reducing inflammation and airway hyperresponsiveness.
• Extra-fine hydrofluoroalkane beclometasone dipropionate · Respiratory
  Beclometasone dipropionate is a corticosteroid that works by reducing inflammation in the body.
• Extra-fine hydrofluoroalkane-beclomethasone dipropionate · Respiratory
  Glucocorticoid receptor agonist
• Extra-fine hydrofluoroalkane beclomethasone MDI · Respiratory
  Glucocorticoid receptor agonist
• Fluticasone propionate metred dose inhaler · Respiratory
  Fluticasone propionate is a corticosteroid that works by reducing inflammation in the lungs.
• Hydrofluoroalkane beclomethasone metred dose inhaler

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Research in Real-Life Ltd portfolio CI brief
• Research in Real-Life Ltd pipeline updates RSS